Aytu BioPharma(us:AYTU)
1.44
+4.35%
Updated on 2024-12-23
Open:1.38
Close:1.44
High:1.45
Low:1.35
Pre Close:1.38
Volume:29463.00
Amount:41485.13
Turnover:0.48%
Shares:6.15M
MarketCap:8.88M
About Aytu BioPharma Company
Aytu Biopharma, Inc. is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers. Its products include Adzenys ER, Adzenys XR-ODT, Cotempla XR-ODT, Karbinal ER, Poly-Vi-Flor, Tri-Vi-Flor, Generic Tussionex, Tuzistra XR, and ZolpiMist. The company was founded on August 9, 2002 and is headquartered in Englewood, CO.
Company Name: Aytu BioPharma
Company Address: 7900 East Union Avenue,Suite 920
Employees: 150
Fiscar Year: 06-30
IPO Date: 2017-10-20
Website: http://www.aytubio.com
CIK: 1385818
View all SEC Filings
About
Aytu Biopharma, Inc. is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers. Its products include Adzenys ER, Adzenys XR-ODT, Cotempla XR-ODT, Karbinal ER, Poly-Vi-Flor, Tri-Vi-Flor, Generic Tussionex, Tuzistra XR, and ZolpiMist. The company was founded on August 9, 2002 and is headquartered in Englewood, CO.
Address:7900 East Union Avenue,Suite 920
Website:http://www.aytubio.com
Market Movers